Report: Current IP System Stifles Biotech Innovation, Impedes Rx Access in Developing World | GenomeWeb
NEW YORK (GenomeWeb News) - The world’s intellectual property system is broken, stifling innovation and stopping life-saving technologies from reaching the people who need them most in developed and developing countries, according to a report released this week by an international coalition of experts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.